DAVIE, Rebecca Louise,EDWARDS, Hannah Joy,EVANS, David Michael,HODGSON, Simon Teanby,PETHEN, Stephen John,ROOKER, David Philip
申请号：
SG11201809922Y
公开号：
SG11201809922YA
申请日:
2017.05.31
申请国别(地区):
SG
年份:
2018
代理人:
摘要：
The present invention provides a selection of compounds of formula (I): (I) compositions comprising such compounds； the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated)； and methods of treating patients with such compounds； wherein R5,R6,R7, A, B,W, X, Y and Z are as defined herein.
